Warthin's tumor surgery: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
Nazia Fuad (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
{{Warthin's tumor}} | {{Warthin's tumor}} | ||
| Line 7: | Line 8: | ||
* Surgery is the mainstay of treatment for Warthin's tumor. Recurrence is rare, occurring in 6 - 12% of cases. Warthin's tumor is highly unlikely to become [[malignant]]. | * Surgery is the mainstay of treatment for Warthin's tumor. Recurrence is rare, occurring in 6 - 12% of cases. Warthin's tumor is highly unlikely to become [[malignant]]. | ||
* [[Surgery]] should be followed by careful observation to watch for changes in the tumor over time.<ref name="pmid12593546">{{cite journal| author=Gooden E, Witterick IJ, Hacker D, Rosen IB, Freeman JL| title=Parotid gland tumours in 255 consecutive patients: Mount Sinai Hospital's quality assurance review. | journal=J Otolaryngol | year= 2002 | volume= 31 | issue= 6 | pages= 351-4 | pmid=12593546 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12593546 }} </ref> Frey syndrome has been successfully treated with injections of botulinum toxin A.<ref>Salivary gland tumor. Cancer.gov (2016). http://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq Accessed on January 4, 2016</ref> | * [[Surgery]] should be followed by careful observation to watch for changes in the tumor over time.<ref name="pmid12593546">{{cite journal| author=Gooden E, Witterick IJ, Hacker D, Rosen IB, Freeman JL| title=Parotid gland tumours in 255 consecutive patients: Mount Sinai Hospital's quality assurance review. | journal=J Otolaryngol | year= 2002 | volume= 31 | issue= 6 | pages= 351-4 | pmid=12593546 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12593546 }} </ref> Frey syndrome has been successfully treated with injections of botulinum toxin A.<ref>Salivary gland tumor. Cancer.gov (2016). http://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq Accessed on January 4, 2016</ref> | ||
'''Complications of surgery:''' | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 17:33, 6 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
|
Warthin's tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Warthin's tumor surgery On the Web |
|
American Roentgen Ray Society Images of Warthin's tumor surgery |
|
Risk calculators and risk factors for Warthin's tumor surgery |
Overview
Surgery is the mainstay of treatment for Warthin's tumor.
Surgery
- Surgery is the mainstay of treatment for Warthin's tumor. Recurrence is rare, occurring in 6 - 12% of cases. Warthin's tumor is highly unlikely to become malignant.
- Surgery should be followed by careful observation to watch for changes in the tumor over time.[1] Frey syndrome has been successfully treated with injections of botulinum toxin A.[2]
Complications of surgery:
References
- ↑ Gooden E, Witterick IJ, Hacker D, Rosen IB, Freeman JL (2002). "Parotid gland tumours in 255 consecutive patients: Mount Sinai Hospital's quality assurance review". J Otolaryngol. 31 (6): 351–4. PMID 12593546.
- ↑ Salivary gland tumor. Cancer.gov (2016). http://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq Accessed on January 4, 2016